106 related articles for article (PubMed ID: 6113584)
1. [Long-term treatment of outpatients with depot neuroleptics (author's transl)].
Saameli W
Schweiz Rundsch Med Prax; 1981 Feb; 70(6):206-10. PubMed ID: 6113584
[No Abstract] [Full Text] [Related]
2. [Prophylactic efficacy of long-acting vs. short-acting neuroleptics in schizophrenic out-patients (author's transl)].
Tegeler J; Lehmann E; Stockschlaeder M
Nervenarzt; 1980 Nov; 51(11):654-61. PubMed ID: 6109262
[No Abstract] [Full Text] [Related]
3. [Depot neuroleptics in social psychiatric practice].
Pruss U; Rose HK; Zechner A
Psychiatr Prax; 1984 Jul; 11(4):101-8. PubMed ID: 6148764
[TBL] [Abstract][Full Text] [Related]
4. [Effects of depot neuroleptics on pituitary hormone secretion (author's transl)].
Czernik A; Kleesiek K
Nervenarzt; 1979 Aug; 50(8):527-33. PubMed ID: 43482
[No Abstract] [Full Text] [Related]
5. [The psychoprophylactic importance of treatment with depot neuroleptics in schizophrenia].
Chiriţă V; Stanciu J; Pirozynski T
Rev Med Chir Soc Med Nat Iasi; 1989; 93(3):497-500. PubMed ID: 2576888
[TBL] [Abstract][Full Text] [Related]
6. Depot neuroleptic therapy: clinical considerations.
Remington GJ; Adams ME
Can J Psychiatry; 1995 Apr; 40(3 Suppl 1):S5-11. PubMed ID: 7627927
[TBL] [Abstract][Full Text] [Related]
7. [Schizophrenia: prophylaxis prevents recurrence. Low dose depot neuroleptics--an exit from the "revolving door" psychiatry].
Fortschr Med Suppl; 1993; 147():1-15. PubMed ID: 9260317
[No Abstract] [Full Text] [Related]
8. [Long-term therapy with depot neuroleptics. Prevention of recurrence in chronic schizophrenic patients].
Bergener M; Husser J; Kranzhoff EU; Charap A
Fortschr Med; 1986 Oct; 104(40):756-60. PubMed ID: 2877927
[No Abstract] [Full Text] [Related]
9. [Treatment of schizophrenic psychoses by sustained-action neuroleptics in psychiatric outpatients' treatment (author's transl)].
Polácek J
Cesk Psychiatr; 1982 Feb; 78(1):49-55. PubMed ID: 7060182
[No Abstract] [Full Text] [Related]
10. Suicidal risk in the treatment of outpatient schizophrenics with long-acting neuroleptics.
Niturad A; Nicholschi-Oproiu L
Agressologie; 1978; 19(C):145-8. PubMed ID: 35993
[No Abstract] [Full Text] [Related]
11. [Is depot formulation a long-term optimal treatment option?].
Musch A
Med Monatsschr Pharm; 2005 Nov; 28(11):414-6. PubMed ID: 16309031
[No Abstract] [Full Text] [Related]
12. [Treatment of schizophrenia using depot neuroleptics (author's transl)].
Faltus F; Soucek K
Cesk Psychiatr; 1976 Jun; 72(3):170-5. PubMed ID: 963807
[No Abstract] [Full Text] [Related]
13. Eleven years of experience with depot neuroleptics.
Gross H; Kaltenbäck E; Pfolz H
Acta Psychiatr Belg; 1981; 81(2):128-32. PubMed ID: 6117183
[TBL] [Abstract][Full Text] [Related]
14. Longterm maintenance therapy with depot haloperidol in schizophrenia.
Zbytovský J
Homeost Health Dis; 1991; 33(5-6):287. PubMed ID: 18265499
[No Abstract] [Full Text] [Related]
15. Depot neuroleptics : a Scandinavian view.
Dencker SJ
Acta Psychiatr Belg; 1981; 81(2):115-20. PubMed ID: 6117182
[TBL] [Abstract][Full Text] [Related]
16. [The role of depot neuroleptics for the longterm treatment of schizophrenic patients (author's transl)].
Woggon B; Angst J
Schweiz Rundsch Med Prax; 1977 Apr; 66(14):421-7. PubMed ID: 866293
[No Abstract] [Full Text] [Related]
17. Management of schizophrenia. Long-term clinical studies with special reference to the combination of psychotherapy with depot neuroleptics.
Lindberg D
Acta Psychiatr Scand Suppl; 1981; 289():1-26. PubMed ID: 6110314
[No Abstract] [Full Text] [Related]
18. The risk/benefit ratio of depot neuroleptics: a Scandinavian perspective.
Dencker SJ
J Clin Psychiatry; 1984 May; 45(5 Pt 2):22-7. PubMed ID: 6143744
[TBL] [Abstract][Full Text] [Related]
19. [The impact of antipsychotic medication on the incidence and the costs of inpatient treatment in people with schizophrenia: results from a prospective observational study].
Kilian R; Angermeyer MC
Psychiatr Prax; 2004 Apr; 31(3):138-46. PubMed ID: 15042477
[TBL] [Abstract][Full Text] [Related]
20. A pharmacoeconomic model of outpatient antipsychotic therapy in "revolving door" schizophrenic patients.
Glazer WM; Ereshefsky L
J Clin Psychiatry; 1996 Aug; 57(8):337-45. PubMed ID: 8752015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
